Northern Trust
TELO icon

Northern Trust’s Telomir Pharmaceuticals TELO Stock Holding History

Northern Trust’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.4K Hold
41,844
– – ﹤0.01% 4230
2025
Q4 		$55.7K Hold
41,844
– – ﹤0.01% 4262
2025
Q3 		$58.2K Hold
41,844
– – ﹤0.01% 4258
2025
Q2 		$52.3K Sell
41,844
-112,228
-73% -$259K ﹤0.01% 4225
2025
Q1 		$498K Buy
154,072
+2,444
+2% +$10.7K ﹤0.01% 3581
2024
Q4 		$625K Buy
151,628
+102,948
+211% +$485K ﹤0.01% 3577
2024
Q3 		$313K Buy
+48,680
New +$237K ﹤0.01% 3720

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust's TELO Position: Q1 2026 in Review

Northern Trust held its Telomir Pharmaceuticals (TELO) position steady in Q1 2026 at 41,844 shares worth $54.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Northern Trust first reported a position in TELO in Q3 2024 and has held it in 7 quarters since. The position peaked at $625K in Q4 2024. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Northern Trust held 41,844 shares of Telomir Pharmaceuticals worth $54.4K as of Q1 2026.
  • Northern Trust left its Telomir Pharmaceuticals share count unchanged in Q1 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4230 holding.
  • Northern Trust first reported a position in Telomir Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Northern Trust's Telomir Pharmaceuticals position peaked at $625K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.